📖 Approx. 10 minutes
In recent years, M&A (Mergers and Acquisitions) in the healthcare industry has gained attention as a viable option for resolving succession issues and expanding businesses. Dermatology clinics, in particular, are attracting significant interest as M&A targets, driven by the increasing demand for general dermatology due to an aging population and the growth of the aesthetic medicine market. Clinics that also offer aesthetic dermatology services are particularly highly valued by potential buyers due to their profitability. This article provides a professional perspective on the key valuation points, legal and tax considerations, and strategies for smooth succession for medical corporation chairpersons, clinic directors, and those considering acquiring medical institutions, especially those involved in dermatology clinics, particularly those with integrated aesthetic dermatology services.
Background and Appeal of Active M&A in Dermatology Clinics
Several factors contribute to the increased M&A activity in dermatology clinics. Firstly, in Japan’s aging society, the needs of patients with skin conditions such as atopic dermatitis, shingles, and skin cancer are steadily increasing. This ensures a stable demand for general dermatology clinics primarily focused on insurance-based services, making them attractive business foundations.
On the other hand, the rapid expansion of the aesthetic medicine market is a major driving force behind M&A in dermatology clinics. Aesthetic dermatology, which primarily focuses on self-pay services like laser treatments, hyaluronic acid injections, and Botox treatments, generally offers higher profit margins compared to insurance-based services, making it easier to achieve business stability and growth strategies. Clinics that combine general dermatology with aesthetic services often have a balanced business model, attracting patients through insurance while increasing profitability through self-pay treatments, making them highly attractive investment targets for buyers.
For sellers, reasons for considering M&A may include a lack of successors due to the aging of physicians, the need to revise management structures with changes in medical corporation members, or the need to adapt to functional differentiation required by regional medical plans. For buyers, acquiring an existing clinic allows them to avoid the significant time, cost, and risks associated with starting a new practice, enabling immediate business operations.
Types of Medical Corporations and Legal Considerations in M&A
Understanding the type of corporate entity is crucial when considering M&A for medical corporations. The main types are “Medical Corporation Associations (with or without equity interests)” and “Medical Foundations.” The M&A methods and legal/tax treatments differ significantly for each. Notably, the procedures and valuation methods for the business transfer of individual clinics (sole proprietorships) and the M&A of medical corporations are fundamentally different.
In the case of medical corporation associations with equity interests, members hold equity interests and have the right to receive a distribution of residual assets upon dissolution of the corporation. In M&A, the common methods involve transferring these equity interests to the buyer or transferring management control by changing the members. The valuation of equity interests is complex, requiring a multi-faceted assessment of past medical fee performance, asset and liability status, and future profitability.
Conversely, medical corporation associations without equity interests do not have the right to distribute residual assets upon dissolution. Some may have a “fund” system instead of equity interests, and the obligation to repay these funds can be a point of contention in M&A. Funds, unlike equity interests, are generally repaid without interest, and their valuation and handling require specialized knowledge. M&A of medical corporations without equity interests is primarily conducted through member changes.
For business transfers of individual clinics, a new business license is required, which can take time to obtain. However, in the M&A of medical corporations (especially when transferring the entire corporation), the corporate entity continues to exist, making the transfer of licenses relatively smoother. Nevertheless, separate procedures are necessary for changes such as the administrator or clinic relocation.
| Item | Medical Corporation with Equity Interests | Medical Corporation without Equity Interests | Individual Clinic (Reference) |
|---|---|---|---|
| Corporate Status | Medical Corporation Association | Medical Corporation Association or Foundation | Sole Proprietorship |
| Equity Interests | Yes (Right to residual asset distribution) | No (Fund system may exist) | No |
| M&A Method | Transfer of equity interests, change of members, business transfer | Change of members, business transfer, fund repayment | Business transfer |
| Valuation Complexity | Complex valuation of equity interests | Valuation and repayment of funds are key issues | Valuation of business value |
| Tax Considerations | Capital gains tax (individual), corporate tax | Corporate tax, tax implications of fund repayment | Capital gains tax (individual) |
| License Transfer | Relatively smooth due to continuation of corporate status | Relatively smooth due to continuation of corporate status | Generally requires re-application for business license |
Valuation Points for Clinics with Integrated Aesthetic Dermatology
M&A for clinics that also offer aesthetic dermatology services involves unique valuation points distinct from those of regular dermatology clinics. Accurately assessing these elements is crucial for determining a fair transfer price and ensuring a smooth M&A process.
- Self-Pay Ratio and Profitability: The proportion of self-pay services in the revenue of aesthetic dermatology is one of the most critical indicators of a clinic’s profitability. Detailed analysis of the price per service, number of procedures, and cost of goods sold for each self-pay menu is essential.
- Customer Base and Repeat Rate: Acquiring repeat customers is vital in aesthetic medicine. The attributes of existing customers, their repeat rates, and the effectiveness of new customer acquisition channels (website, social media, referrals, etc.) are evaluated. The status of digitalization of customer data and medical records is also a key check point.
- Medical Equipment Status: The type, installation date, operational status, maintenance history, and depreciation of high-value aesthetic medical equipment such as laser devices, light therapy machines, and body contouring devices are crucial as they impact the buyer’s initial investment burden. The investment in the latest equipment also influences the valuation.
- Staff Expertise and Retention Rate: In aesthetic medicine, the technical skills and customer service of specialized staff, including nurses and aestheticians, significantly influence the quality of services. The retention rate of staff and their possession of professional qualifications are also important valuation points.
- Service Area Analysis and Location: The clinic’s location directly impacts its ability to attract patients. A comprehensive evaluation includes surrounding demographics, presence of competing clinics, accessibility, and visibility. Aesthetic dermatology, in particular, requires a location that suits the target demographic.
Strengths in M&A for Clinics with Integrated Aesthetic Dermatology
- High Profitability: Attractive due to high profit margins from self-pay services.
- Growth Potential: The aesthetic medicine market is expected to continue growing, offering significant room for business expansion.
- Diverse Patient Base: Capable of meeting both aesthetic and general dermatology needs, facilitating the acquisition of a broad patient base.
- Branding: Specialized aesthetic medical services enhance the clinic’s brand value.
- Patient Acquisition: Self-pay service marketing offers more flexibility, making it easier to implement patient acquisition strategies.
*These strengths are realized through appropriate management strategies and operational efforts.
Impact of Medical Fees, Facility Standards, and Licenses on M&A
Understanding medical fee revisions, facility standards, and various licenses is essential for M&A involving medical institutions. These factors directly impact the post-M&A management of the clinic and require detailed verification during the due diligence (DD) phase.
For dermatology clinics providing insurance-based services, medical fee revisions significantly affect management. Buyers must incorporate potential future revisions as a risk factor in their revenue simulations. The status of facility standards required for specific surgeries or examinations is also important. It is necessary to confirm whether existing facility standards can be maintained post-M&A or if new ones need to be acquired, and to understand the requirements, procedures, and timelines involved.
Opening a medical institution requires a business license based on the Medical Care Act. When inheriting a medical corporation, the corporate entity continues to exist, so re-application for the business license is generally not required. However, if there are changes such as the administrator or medical specialties, or relocation, notification or permission from the relevant public health center or prefecture is necessary. In the case of a business transfer of an individual clinic, it is common for the buyer to obtain a new business license, a process that can take several months. For aesthetic medicine, compliance with medical advertising guidelines is also a point to verify. It is important to check for any inappropriate advertising expressions or past guidance received, and to assess their potential impact on post-M&A advertising strategies.
Furthermore, changes in officers (directors/auditors) or members of a medical corporation require notification to the governing authority. Failure to comply with these procedures can lead to the revocation of licenses or administrative guidance. Therefore, it is crucial to collaborate with M&A specialists and administrative scriveners to ensure proper procedures are followed.
M&A Process and Tax/Legal Precautions
M&A for medical institutions, like that of general companies, proceeds through multiple steps. However, due to the addition of unique legal and tax issues specific to the healthcare industry, careful handling is required. Expert advice is indispensable throughout the entire M&A process.
The M&A process generally follows these steps: “M&A strategy formulation/consultation,” “Target search/matching,” “Top management meetings/Letter of Intent,” “Due Diligence (DD),” “Final negotiations/Final agreement,” and “Closing/Succession.” DD, in particular, is a critical stage where the seller’s clinic’s financial status, legal risks, personnel structure, medical equipment status, patient information management system, and license compliance are thoroughly investigated. For clinics with integrated aesthetic dermatology, contract details related to self-pay services, customer data management, and the legality of marketing strategies are also meticulously examined.
From a tax perspective, capital gains tax is a major issue. When a sole proprietor transfers their business, capital gains tax is levied on the profit from the transfer. Similarly, when equity interests in a medical corporation are transferred, individual shareholders are subject to capital gains tax. Corporate tax and business tax also vary depending on the M&A scheme, necessitating close consultation with a tax accountant in advance. For example, the tax treatment of fund repayments for medical corporations without equity interests can be complex and requires careful consideration by specialists.
Additionally, movements in regional medical plans regarding the reorganization and functional differentiation of medical institutions may influence M&A decisions. It may be important to consider how the clinic’s role will be positioned within the regional medical plan in the future and to gather information and collaborate with administrative bodies.
-
1
M&A Strategy Formulation & Consultation
Clarify M&A objectives, desired conditions, and schedule, and consult with specialized advisors.
-
2
Target Search & Matching
M&A advisors search for targets and match buyers and sellers who meet the criteria.
-
3
Top Management Meetings & Letter of Intent
After meetings between management, basic M&A terms (e.g., estimated transfer price) are agreed upon, and a Letter of Intent is signed.
-
4
Due Diligence (DD)
The buyer conducts a detailed investigation and evaluation of the seller’s clinic’s finances, legal aspects, business operations, etc.
-
5
Final Negotiations & Final Agreement
Based on the DD results, final terms are negotiated, and the final agreement, such as a stock transfer agreement or business transfer agreement, is signed.
-
6
Closing & Succession
Payment is made and management control is transferred according to the agreement, completing the M&A. Smooth business succession then proceeds.
Utilizing Experts and Precautions for Successful M&A
To achieve successful M&A for dermatology clinics, especially those with integrated aesthetic dermatology services, collaboration with experts in M&A advisory, law, and taxation is essential. These professionals provide comprehensive support, including handling complex legal and tax procedures, appropriate business valuation, and negotiation strategy development.
Information management and confidentiality are among the most critical aspects of the M&A process. The execution of a Non-Disclosure Agreement (NDA) is mandatory to prevent the leakage of sensitive information such as the seller’s business data, patient information, and the buyer’s strategies. Furthermore, maintaining employee employment and ensuring smooth handover are crucial for post-M&A business continuity and patient satisfaction. Clear communication with employees and careful negotiation of employment conditions are required. In particular, retaining specialized staff in aesthetic dermatology, who are valuable assets to the clinic, requires careful consideration.
Moreover, preserving the clinic’s brand image and the trust relationship with patients is vital. A strategy must be developed to carefully explain the transition to the new management structure and maintain or build upon the trust relationship, ensuring patients can continue to visit with confidence. M&A is not merely a transfer of management control; it is essential to aim for long-term success with consideration for contributing to regional healthcare.
M&A for dermatology clinics, particularly those with integrated aesthetic dermatology services, requires a high level of specialized knowledge and experience due to their unique characteristics. The key to success lies in comprehensively considering a wide range of issues, including medical corporation types, equity interests, funds, medical fees, licenses, and taxation, and developing appropriate strategies. At M&A Medical, we leverage our extensive knowledge and network specialized in the healthcare industry to strongly support your M&A endeavors. We encourage you to take advantage of our free consultation service when considering M&A.
Consult M&A Medical for Medical Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing succession issues, as well as strategic acquisitions, on a success-fee basis.
- Initial consultation and preliminary assessment are free
- No retainer or monthly fees (success fee only)
- Strict confidentiality (proceeds after signing NDA)
- Support available nationwide across all 47 prefectures and all medical specialties
Please consult us early, even in the initial stages of consideration, if you wish to know the market value, have no successor, or are considering joining a group.